Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Average (2020 - 2025)

Celularity (CELU) has disclosed Equity Average for 6 consecutive years, with -$29.1 million as the latest value for Q4 2025.

  • For Q4 2025, Equity Average fell 322.67% year-over-year to -$29.1 million; the TTM value through Dec 2025 reached -$29.1 million, down 322.67%, while the annual FY2025 figure was -$14.6 million, 158.69% down from the prior year.
  • Equity Average hit -$29.1 million in Q4 2025 for Celularity, down from -$22.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $181.6 million in Q4 2022 and bottomed at -$630.1 million in Q2 2021.
  • Average Equity Average over 5 years is -$18.3 million, with a median of $32.6 million recorded in 2023.
  • Year-over-year, Equity Average skyrocketed 156.95% in 2022 and then tumbled 322.67% in 2025.
  • Celularity's Equity Average stood at $97.8 million in 2021, then surged by 85.62% to $181.6 million in 2022, then plummeted by 80.39% to $35.6 million in 2023, then tumbled by 63.32% to $13.1 million in 2024, then crashed by 322.67% to -$29.1 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at -$29.1 million, -$22.8 million, and -$15.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.